cancer

Cancer research reveals how chemo impact cells at the molecular level

Proteins play a central role in virtually every disease. They are the building blocks of life, serving as essential components…

1 year ago

AI model for thyroid cancer diagnosis, with over 90% accuracy and reduced consultation preparation time

An interdisciplinary research team from the LKS Faculty of Medicine of the University of Hong Kong (HKUMed), the InnoHK Laboratory…

1 year ago

Throwing a ‘spanner in the works’ of our cells’ machinery could help fight cancer, fatty liver disease… and hair loss

Fifty years since its discovery, scientists have finally worked out how a molecular machine found in mitochondria, the 'powerhouses' of…

1 year ago

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept pancreatic…

1 year ago

Blind to the burn: Misconceptions about skin cancer risk in the US

Skin cancer is the most common cancer in the United States and a significant health issue, with millions of non-melanoma…

1 year ago

Targeted alpha therapy: Breakthrough in treating refractory skin cancer

Metastatic melanoma, also known as stage IV melanoma, is a type of skin cancer that spreads to other parts of…

1 year ago

Disruption of a single amino acid in a cellular protein makes breast cancer cells behave like stem cells

Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumour growth by increasing cancer stemness in an…

1 year ago

Researchers find improved method for treating rare, aggressive, pregnancy-related cancer

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new…

1 year ago

New research unlocks key to long-lasting immune response in cancer and chronic diseases

Prolonged illnesses like cancer and chronic infections often leave the immune system in a state of exhaustion, where its frontline…

1 year ago

Combination of dual-targeted therapies and chemotherapy shows high response rates in BRAF-mutated metastatic colorectal cancer

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies encorafenib and…

1 year ago